This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]

  • P53 binding
  • DNA binding
  • Enables RNA binding
  • Enables cyclin-dependent protein serine/threonine kinase inhibitor activity
  • Enables protein binding
  • Located_in nucleus
  • Nucleoplasm
  • Nucleolus
  • Located in cytoplasm
  • Mitochondrion
  • Involved in regulation of cyclin-dependent protein serine/threonine kinase activity
  • Protein polyubiquitination
  • Involved in negative regulation of cell-matrix adhesion
  • rRNA processing
  • Negative regulation of protein kinase activity
  • Melanoma-Pancreatic Cancer Syndrome
  • Melanoma, Cutaneous Malignant 2
  • Melanoma-Astrocytoma Syndrome
  • Melanoma
  • Hereditary Melanoma
  • Lip And Oral Cavity Cancer
  • Dysplastic Nevus Syndrome
  • Melanoma, Cutaneous Malignant 1
  • B-Lymphoblastic Leukemia/Lymphoma With Recurrent Genetic Abnormality
  • Precursor T-Cell Acute Lymphoblastic Leukemia
  • Inherited Cancer-Predisposing Syndrome
  • Cutaneous Telangiectasia And Cancer Syndrome, Familial
  • Tumor Predisposition Syndrome
  • Lipoprotein Quantitative Trait Locus
  • Pancreatic Adenocarcinoma
  • Li-Fraumeni Syndrome
  • Cervical Adenocarcinoma
  • Penile Cancer
  • Skin Melanoma
  • Cervical Intraepithelial Neoplasia
  • Papilloma
  • Human Papillomavirus Infectious Disease
  • Oropharynx Cancer
  • Autosomal dominant inheritance
  • Abnormal morphology of female internal genitalia
  • Abnormality of male internal genitalia
  • Abnormality of male external genitalia
  • Abnormal testis morphology
  • Abnormality of the kidney
  • Abnormality of the genital system
  • Abnormality of the urinary system
  • Abnormality of the genitourinary system
  • Abnormality of the ovary
  • Male reproductive system neoplasm
  • Abnormality of the musculoskeletal system

CDKN2A Localizations – Subcellular Localization Database

EmwOwn work. Structure of the CDKN2A protein. Based on PyMOL rendering of PDB 1a5e.

Gene Location